Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

11.04.2024 - LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescription treatment for acne vulgaris, PrARAZLOTM (tazarotene lotion, 0.045% w/w), is ... Seite 1

Related Keywords

Canada ,Vancouver ,British Columbia ,United Kingdom ,Canadians ,Canadian ,British ,Christina Han ,Cees Heiman ,Bausch Health ,Department Of Dermatology ,University Of British Columbia ,Rosacea Society Of Canada ,Senior Vice President ,Clinical Assistant Professor ,Executive Director ,Rosacea Society ,